Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 1/20 | 0.33 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30799489 | 0.90 | CTSC (0.35) | CTSC | |
| SCHEMBL22369842 | 0.88 | CTSC (0.34) | CTSC | |
| SCHEMBL13958826 | 0.88 | CTSC (0.34) | CTSC | |
| SCHEMBL30946342 | 0.87 | CNR2 (0.33) | CTSC | |
| SCHEMBL16362464 | 0.87 | CTSC (0.32) | CTSC | |
| SCHEMBL31388739 | 0.85 | GRB2 (0.36) | — | |
| SCHEMBL30987834 | 0.81 | — | — | |
| SCHEMBL3835499 | 0.80 | LTA4H (0.33) | — | |
| SCHEMBL3835494 | 0.80 | LTA4H (0.33) | — | |
| Histidine SCHEMBL23722163 | 0.80 | SLC7A5 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119775356-A | Preparation method of GLP-1 or analogue thereof | 汉肽生物医药集团有限公司 | 2025-04-08 | — | — | CN | claimed |
| WO-2025069009-A1 | ROCK2 INHIBITORS IN THE TREATMENT OF OBESITY | GRAVITON BIOSCIENCE BV (NL) | 2025-04-03 | — | — | WO | claimed |
| CN-117586375-B | Method for preparing semaglutin | 苏州金顶生物有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-117586375-A | Method for preparing semaglutin | 苏州金顶生物有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-116693652-B | GLP-1/GIP receptor dual agonist derivative and preparation method and application thereof | 北京惠之衡生物科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-117007704-A | Liquid phase analysis method for quantitatively detecting isomer content in dipeptide | 南京汉欣医药科技有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-116693652-A | GLP-1/GIP receptor dual agonist derivative and preparation method and application thereof | 北京惠之衡生物科技有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116355042-A | Fmoc-His-Aib-OH and R1 preparation method | 上海奥博生物医药股份有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-115322250-B | Semex lattice Synthesis method of lupeptide | 南京汉欣医药科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260000770-A1 | LIQUID PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF | BEIJING QL BIOPHARMACEUTICAL CO LTD (CN) | 2026-01-01 | — | — | US | disclosed |
| US-20250276068-A1 | PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF | BEIJING QL BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-09-04 | — | — | US | disclosed |
| EP-4600265-A1 | PREPARATION METHOD FOR SEMAGLUTIDE, AND INTERMEDIATE | Yangzhou Aurisco Pharmaceutical Co., Ltd (CN) | 2025-08-13 | — | — | EP | disclosed |
| US-12383623-B2 | Liquid pharmaceutical compositions of polypeptide conjugates and methods of uses thereof | BEIJING QL BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-08-12 | — | — | US | disclosed |
| CN-119913183-A | Recombinant escherichia coli high-efficiency soluble expression semeglutide 9-37 amino peptide and purification method | 江南大学 | 2025-05-02 | — | — | CN | disclosed |
| CN-114790474-B | Preparation method of Somalutide | 北京惠之衡生物科技有限公司 | 2022-08-26 | — | — | CN | disclosed |
| CN-114790474-A | Preparation method of Somalutide | 北京惠之衡生物科技有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-114729060-A | Polypeptide conjugates and methods of use | 北京质肽生物医药科技有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20220133856-A1 | POLYPEPTIDE CONJUGATES AND METHODS OF USES | BEIJING QL BIOPHARMACEUTICAL CO., LTD. (CN) | 2022-05-05 | — | — | US | disclosed |
| CN-111378027-B | Preparation method of somaglutide precursor | 万新医药科技(苏州)有限公司 | 2022-04-15 | — | — | CN | disclosed |
| WO-2022068920-A1 | POLYPEPTIDE CONJUGATES AND METHODS OF USES | BEIJING QL BIOPHARMACEUTICAL CO., LTD. (CN) | 2022-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12383623-B2 | Liquid pharmaceutical compositions of polypeptide conjugates and methods of uses thereof | GLP1R, GIPR, IAPP | CTSC 49/4885SHMT1 2706/4885 |
| US-20250276068-A1 | PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF | GLP1R, GIPR, IAPP | CTSC 41/4885SHMT1 2442/4885 |
| US-20260000770-A1 | LIQUID PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF | GLP1R, GIPR, VIP | CTSC 282/4885SHMT1 4413/4885 |
| US-20220133856-A1 | POLYPEPTIDE CONJUGATES AND METHODS OF USES | GLP1R, GIPR, IAPP | CTSC 44/4885SHMT1 2279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.